ACC Cardio-oncology Course Equips Clinicians, Researchers with Tools to Improve Cardiovascular Care for Cancer Patients

The conference aims to ensure the care team stays at the leading edge of this evolving field

The American College of Cardiology (ACC) will host the annual Advancing the Cardiovascular Care of the Oncology Patient course on April 14-16, 2023, in Washington, DC. The course is intended for all members of the interprofessional care team—including cardiologists, oncologists, pharmacists and nurses—and aims to equip the global cardio-oncology community with the tools they need to improve patient care.

Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, will serve as co-directors for the course, which will be available both in-person and online. The course will bring together clinicians and researchers from across the globe to share emerging strategies and best practices for managing the cardiovascular health of cancer patients.

“I am proud to say that the ACC course has set the standards for cardio-oncology education, including joint presentations of oncologists and cardiologists modeling real-life patient care and collaboration across CV and oncology teams,” Barac said. “This year, our theme is collaboration and innovation through science and for our patients. I am very excited about the first-ever joint sessions with the American Society of Clinical Oncology and the American Society of Hematology that are a testament of the commitment of our professional societies to collaborate and address the gaps that exist across specialties.”

Can’t Miss Sessions:

  • Pharmacology Essentials for Cardio-Oncology Practice
  • How to Build and Grow a Cardio-Oncology Program
  • The Global Burden and Significance of Cancer and Cardiovascular Disease
  • Cardiovascular Disparities in Cancer Patients and Survivors: Strategies to Implement Inclusive, Equitable Care
  • Physical Activity Interventions in Our Cancer Patients and Survivors: Why, When, and How?

Posters

The following abstract titles are a selection of posters being presented during the conference. All ACC Advancing the Cardiovascular Care of the Oncology Patients posters and abstracts are embargoed until Friday, April 14, 2023, at 9 a.m. ET.

  • Racial Disparities in Cardiotoxicity Following Cancer Treatment: A Systematic Review and Meta-Analysis
  • Assessment of Detectable Atherosclerosis on Computed Tomography Imaging in Breast Cancer Patients Entering Treatment
  • Prevalence of Statin Use and Dyslipidemia Screening for Secondary Cardiovascular Prevention in Patients with Cancer
  • SGLT2 Inhibitors are Associated with a Lower Risk of Malnutrition and Cachexia in Patients with Heart Failure Receiving Anthracycline Treatment
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version